DRD1 and Cognitive impairment: This focus was motivated by previous findings demonstrating that Per2 KO leads to cognitive impairments through DRD1-PKA-CREB signaling changes [14], and METH treatment restores both cognitive function and gene expression levels (Fig. 2A and Supplementary Fig. 1).